Faron Pharmaceuticals Oy

29.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:FARNHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (17.78%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.12
PE TTM —
TSR TTM (85.29%)
Mkt cap £59.90M
ROIC (68.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
30p
2.99%
(81.44%)
Hold 10|2|1|12|12
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.44
0.46
0.48
0.53
7.45%
14.61%
23.14%
21.61%
Revenue€M
4.681
4.950
4.895
5.096
9.38%
12.73%
9.27%
10.56%
Peers (US$83.37M)
Cap (US$)
PE
162.4M
—
Capital
TTM
5Y
10Y
Leveragex
1.595
(0.156)
(0.145)
EBIT/Intx
0.484
0.089
0.094
Own earn%
(31.88)
50.91
67.32
Sh yield%
25.89
40.25
40.19
Owners
Insiders/Inst%
3.03
46.37
Short interest%
2.23
SBC / revenue%
3.57
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
10–17
$1 testx
—
Incr. ROIC%
4